X-linked retinitis pigmentosa: clinical manifestations and diagnosis

Abstract

X-linked retinitis pigmentosa (XLRP) is considered one of the most severe forms of retinitis pigmentosa (RP). It accounts for 6–20% of all disease cases. Nowadays, mutations in three genes (RP2, RPGR, and OFD1) have been identified to cause XLRP. Early symptoms are impaired night vision and/or visual field loss. The subsequent damage to the cones results in decreased visual acuity, photophobia and color vision disorders may also be observed. Ophthalmoscopy shows waxy optic disc pallor, vasoconstriction, foci of hypopigmentation and/or hyperpigmentation, sometimes in form of bone-spicule in the peripheral retina. Gradual reduction in amplitudes of light-adapted and dark-adapted electroretinograms (ERG) is specific for RP. Microperimetry reveals reduced average light sensitivity and paracentral ring scotoma despite normal or slightly decreased visual acuity. Optical coherence tomography (OCT) demonstrates destructed outer retinal layers, short-wavelength autofluorescence imaging shows a Robson-Holder ring. X-linked RP in females is almost always associated with notable variability in severity from asymptomatic cases to severe ones as in male patients. Night blindness is reported in 50% of female carriers of X-linked RP, visual acuity and amplitude of light-adapted and dark-adapted ERG are reduced in most cases. Fundus changes are observed in 87% of female carriers. A tapetal reflex is the most common. Foci of hypo- and hyperpigmentation, bone-spicule-like pigment clumping, extensive retinal pigment epithelial and choroidal atrophy are also reported. In the vast majority (63–79%) of female carriers of X-linked RP, short-wavelength autofluorescence images show radial patterns.

Keywords

X-linked retinitis pigmentosa / tapetal reflex / genetic carrier / review

References

[1] Tsang SH, Sharma T. X-linked retinitis pigmentosa. Adv Exp Med Biol. 2018;1085:31–35. doi: 10.1007/978-3-319-95046-4_8

[2] Tsang S.H., Sharma T. X-linked retinitis pigmentosa // Adv Exp Med Biol. 2018. Vol. 1085. Р. 31–35. doi: 10.1007/978-3-319-95046-4_8

[3] Raghupathy RK, McCulloch DL, Akhtar S, et al. Zebrafish model for the genetic basis of X-linked retinitis pigmentosа. Zebrafish. 2013;10(1):62–69. doi: 10.1089/zeb.2012.0761

[4] Raghupathy R.K., McCulloch D.L., Akhtar S., et al. Zebrafish model for the genetic basis of X-linked retinitis pigmentosа // Zebrafish. 2013. Vol. 10, N 1. P. 62–69. doi: 10.1089/zeb.2012.0761

[5] Martinez-Fernandez De La Camara C, Nanda A, Salvetti AP, et al. Gene therapy for the treatment of X-linked retinitis pigmentosa. Exp Opin Orphan Drugs. 2018;6(3):167–177. doi: 10.1080/21678707.2018.1444476

[6] Martinez-Fernandez De La Camara C., Nanda A., Salvetti A.P., et al. Gene therapy for the treatment of X-linked retinitis pigmentosa // Exp Opin Orphan Drugs. 2018. Vol. 6, N 3. P. 167–177. doi: 10.1080/21678707.2018.1444476

[7] Fahim AT, Daiger SP, Weleber RG, et al. Nonsyndromic retinitis pigmentosa overview. Seattle (WA): University of Washington, Seattle; 1993.

[8] Fahim A.T., Daiger S.P., Weleber R.G., et al. Nonsyndromic retinitis pigmentosa overview. Seattle (WA): University of Washington, Seattle, 1993.

[9] Lyraki R, Megaw R, Hurd T. Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations. Biochem Soc Trans. 2016;44(5):1235–1244. doi: 10.1042/BST20160148

[10] Lyraki R., Megaw R., Hurd T. Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations // Biochem Soc Trans. 2016. Vol. 44, N 5. P. 1235–1244. doi: 10.1042/BST20160148

[11] Hereditary and congenital diseases of the retina and optic nerve: a guide for doctors. Ed. by A.M. Shamshinova. Moscow: Meditsina; 2001. 528 р. (In Russ.)

[12] Наследственные и врожденные заболевания сетчатки и зрительного нерва: руководство для врачей / под ред. А.М. Шамшиновой. Москва: Медицина, 2001. 528 с.

[13] Padnick-Silver L, Kang Derwent JJ, Giuliano E, et al. Retinal oxygenation and oxygen metabolism in Abissinian with a hereditary retinal degeneration. Invest Ophtalmol Vis Sci. 2006;47(8):3683–3689. doi: 10.1167/iovs.05-1284

[14] Padnick-Silver L., Kang Derwent J.J., Giuliano E., et al. Retinal oxygenation and oxygen metabolism in Abissinian with a hereditary retinal degeneration // Invest Ophtalmol Vis Sci. 2006. Vol. 47, N 8. P. 3683–3689. doi: 10.1167/iovs.05-1284

[15] Li L, Rao KN, Zheng-Le Y, et al. Loss of retinitis pigmentosa 2 (RP2) protein predominantly affects cone photoreceptor sensory cilium elongation in mice. Cytoskeleton (Hoboken). 2015;72(9):447–454. doi: 10.1002/cm.21255

[16] Li L., Rao K.N., Zheng-Le Y., et al. Loss of retinitis pigmentosa 2 (RP2) protein predominantly affects cone photoreceptor sensory cilium elongation in mice // Cytoskeleton (Hoboken). 2015. Vol. 72, N 9. P. 447–454. doi: 10.1002/cm.21255

[17] Li L, Khan N, Hurd T, et al. Ablation of the X-linked retinitis pigmentosa 2 (Rp2) gene in mice results in opsin mislocalization and photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2013;54(7):4503–4511. doi: 10.1167/iovs.13-12140

[18] Li L., Khan N., Hurd T., et al. Ablation of the X-linked retinitis pigmentosa 2 (Rp2) gene in mice results in opsin mislocalization and photoreceptor degeneration // Invest Ophthalmol Vis Sci. 2013. Vol. 54, N 7. P. 4503–4511. doi: 10.1167/iovs.13-12140

[19] Georgiou M, Robson AG, Jovanovic K, et al. RP2-associated X-linked retinopathy: clinical findings, molecular genetics, and natural history. Ophthalmology. 2023;130(4):413–422. doi: 10.1016/j.ophtha.2022.11.015

[20] Georgiou M., Robson A.G., Jovanovic K., et al. RP2-associated X-linked retinopathy: clinical findings, molecular genetics, and natural history // Ophthalmology. 2023. Vol. 130, N 4. P. 413–422. doi: 10.1016/j.ophtha.2022.11.015

[21] Tzu JH, Arguello T, Berrocal AM, et al. Clinical and electrophysiologic characteristics of a large kindred with x-linked retinitis pigmentosa associated with the RPGR locus. Ophthalmic Genet. 2015;36(4):321–326. doi: 10.3109/13816810.2014.886267

[22] Tzu J.H., Arguello T., Berrocal A.M., et al. Clinical and electrophysiologic characteristics of a large kindred with x-linked retinitis pigmentosa associated with the RPGR locus // Ophthalmic Genet. 2015. Vol. 36, N 4. P. 321–326. doi: 10.3109/13816810.2014.886267

[23] Milash SV, Zolnikova IV, Kadyshev VV. Multimodal imaging of hereditary retinal dystrophies (a series of clinical cases). Russian Ophihalmological Journal. 2020;13(4):75–82. EDN: IMQTHJ doi: 10.21516/2072-0076-2020-13-4-75-82

[24] Милаш С.В., Зольникова И.В., Кадышев В.В. Мультимодальная визуализация наследственных дистрофий сетчатки (серия клинических случаев) // Российский офтальмологический журнал. 2020. Т. 13, № 4. С. 75–82. EDN: IMQTHJ doi: 10.21516/2072-0076-2020-13-4-75-82

[25] Kurata K, Hosono K, Hayashi T, et al. X-linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers. Int J Mol Sci. 2019;20(6):1518. doi: 10.3390/ijms20061518

[26] Kurata K., Hosono K., Hayashi T., et al. X-linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers // Int J Mol Sci. 2019. Vol. 20, N 6. P. 1518. doi: 10.3390/ijms20061518

[27] Sharon D, Sandberg MA, Rabe VW, et al. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet. 2003;73(5):1131–1146. doi: 10.1086/379379

[28] Sharon D., Sandberg M.A., Rabe V.W., et al. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa // Am J Hum Genet. 2003. Vol. 73, N 5. P. 1131–1146. doi: 10.1086/379379

[29] Jayasundera T, Branham KE, Othman M, et al. RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa. Arch Ophthalmol. 2010;128(7):915–923. doi: 10.1001/archophthalmol.2010.122

[30] Jayasundera T., Branham K.E., Othman M., et al. RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa // Arch Ophthalmol. 2010. Vol. 128, N 7. P. 915–923. doi: 10.1001/archophthalmol.2010.122

[31] Talib M, van Schooneveld MJ, Thiadens AA, et al. Clinical and genetic characteristics of male patients with RPGR-associated retinal dystrophies: a long-term follow-up study. Retina. 2019;39(6):1186–1199. doi: 10.1097/IAE.0000000000002125

[32] Talib M., van Schooneveld M.J., Thiadens A.A., et al. Clinical and genetic characteristics of male patients with RPGR-associated retinal dystrophies: a long-term follow-up study // Retina. 2019. Vol. 39, N 6. P. 1186–1199. doi: 10.1097/IAE.0000000000002125

[33] Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med. 2020;26(3):354–359. doi: 10.1038/s41591-020-0763-1

[34] Cehajic-Kapetanovic J., Xue K., Martinez-Fernandez de la Camara C., et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR // Nat Med. 2020. Vol. 26, N 3. P. 354–359. doi: 10.1038/s41591-020-0763-1

[35] Menghini M, Cehajic-Kapetanovic J, MacLaren RE. Monitoring progression of retinitis pigmentosa: current recommendations and recent advances. Expert Opin Orphan Drugs. 2020;8(2-3):67–78. doi: 10.1080/21678707.2020.1735352

[36] Menghini M., Cehajic-Kapetanovic J., MacLaren R.E. Monitoring progression of retinitis pigmentosa: current recommendations and recent advances // Expert Opin Orphan Drugs. 2020. Vol. 8, N 2-3. P. 67–78. doi: 10.1080/21678707.2020.1735352

[37] Buckley TM, Jolly JK, Josan AS, et al. Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review. Acta Ophthalmol. 2021;99(8):819–825. doi: 10.1111/aos.14816

[38] Buckley T.M., Jolly J.K., Josan A.S., et al. Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review // Acta Ophthalmol. 2021. Vol. 99, N 8. P. 819–825. doi: 10.1111/aos.14816

[39] Von Krusenstiern L, Liu J, Liao E, et al. Changes in retinal sensitivity associated with cotoretigene toliparvovec in X-linked retinitis pigmentosa with RPGR gene variations. JAMA Ophthalmol. 2023;141(3):275–283. doi: 10.1001/jamaophthalmol.2022.6254

[40] Von Krusenstiern L., Liu J., Liao E., et al. Changes in retinal sensitivity associated with cotoretigene toliparvovec in X-linked retinitis pigmentosa with RPGR gene variations // JAMA Ophthalmol. 2023. Vol. 141, N 3. P. 275–283. doi: 10.1001/jamaophthalmol.2022.6254

[41] Hood DC, Lazow MA, Locke KG, et al. The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52(1):101–108. doi: 10.1167/iovs.10-5799

[42] Hood D.C., Lazow M.A., Locke K.G., et al. The transition zone between healthy and diseased retina in patients with retinitis pigmentosa // Invest Ophthalmol Vis Sci. 2011. Vol. 52, N 1. P. 101–108. doi: 10.1167/iovs.10-5799

[43] Tee JL, Carroll J, Webster AR, Michaelides M. Quantitative analysis of retinal structure using spectral-domain optical coherence tomography in RPGR-associated retinopathy. Am J Ophthalmol. 2017;178:18–26. doi: 10.1016/j.ajo.2017.03.012

[44] Tee J.L., Carroll J., Webster A.R., Michaelides M. Quantitative analysis of retinal structure using spectral-domain optical coherence tomography in RPGR-associated retinopathy // Am J Ophthalmol. 2017. Vol. 178. P. 18–26. doi: 10.1016/j.ajo.2017.03.012

[45] Tang PH, Jauregui R, Tsang SH, et al. Optical coherence tomography angiography of RPGR-associated retinitis pigmentosa suggests foveal avascular zone is a biomarker for vision loss. Ophthalmic Surg Lasers Imaging Retina. 2019;50(2):e44–e48. doi: 10.3928/23258160-20190129-18

[46] Tang P.H., Jauregui R., Tsang S.H., et al. Optical coherence tomography angiography of RPGR-associated retinitis pigmentosa suggests foveal avascular zone is a biomarker for vision loss // Ophthalmic Surg Lasers Imaging Retina. 2019. Vol. 50, N 2. P. e44–e48. doi: 10.3928/23258160-20190129-18

[47] Robson AG, El-Amir A, Bailey C, et al. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2003;44(8):3544–3550. doi: 10.1167/iovs.02-1278

[48] Robson A.G., El-Amir A., Bailey C., et al. Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity // Invest Ophthalmol Vis Sci. 2003. Vol. 44, N 8. P. 3544–3550. doi: 10.1167/iovs.02-1278

[49] Lima LH, Cella W, Greenstein VC, et al. Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa. Retina. 2009;29(7):1025–1031. doi: 10.1097/iae.0b013e3181ac2418

[50] Lima L.H., Cella W., Greenstein V.C., et al. Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa // Retina. 2009. Vol. 29, N 7. P. 1025–1031. doi: 10.1097/iae.0b013e3181ac2418

[51] Oishi A, Ogino K, Makiyama Y, et al. Wide-field fundus autofluorescence imaging of retinitis pigmentosa. Ophthalmology. 2013;120(9):1827–1834. doi: 10.1016/j.ophtha.2013.01.050

[52] Oishi A., Ogino K., Makiyama Y., et al. Wide-field fundus autofluorescence imaging of retinitis pigmentosa // Ophthalmology. 2013. Vol. 120, N 9. P. 1827–1834. doi: 10.1016/j.ophtha.2013.01.050

[53] Lam BL, Davis JL, Gregori NZ. Choroideremia gene therapy. Int Ophthalmol Clin. 2021;61(4):185–193. doi: 10.1097/IIO.0000000000000385

[54] Lam B.L., Davis J.L., Gregori N.Z. Choroideremia gene therapy // Int Ophthalmol Clin. 2021. Vol. 61, N 4. P. 185–193. doi: 10.1097/IIO.0000000000000385

[55] Fishman GA, Weinberg AB, McMahon TT. X-linked recessive retinitis pigmentosa. Clinical characteristics of carriers. Arch Ophthalmol. 1986;104(9):1329–1335. doi: 10.1001/archopht.1986.01050210083030

[56] Fishman G.A., Weinberg A.B., McMahon T.T. X-linked recessive retinitis pigmentosa. Clinical characteristics of carriers // Arch Ophthalmol. 1986. Vol. 104, N 9. P. 1329–1335. doi: 10.1001/archopht.1986.01050210083030

[57] Comander J, Weigel-DiFranco C, Sandberg MA, Berson EL. Visual function in carriers of X-linked retinitis pigmentosa. Ophthalmology. 2015;122(9):1899–1906. doi: 10.1016/j.ophtha.2015.05.039

[58] Comander J., Weigel-DiFranco C., Sandberg M.A., Berson E.L. Visual function in carriers of X-linked retinitis pigmentosa // Ophthalmology. 2015. Vol. 122, N 9. P. 1899–1906. doi: 10.1016/j.ophtha.2015.05.039

[59] Acton JH, Greenberg JP, Greenstein VC, et al. Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa. Exp Eye Res. 2013;113:41–48. doi: 10.1016/j.exer.2013.05.003

[60] Acton J.H., Greenberg J.P., Greenstein V.C., et al. Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa // Exp Eye Res. 2013. Vol. 113. P. 41–48. doi: 10.1016/j.exer.2013.05.003

[61] Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci. 1997;38(10):1983–1997.

[62] Jacobson S.G., Buraczynska M., Milam A.H., et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene // Invest Ophthalmol Vis Sci. 1997. Vol. 38, N 10. P. 1983–1997.

[63] Vingolo EM, Livani ML, Domanico D, et al. Optical coherence tomography and electro-oculogram abnormalities in X-linked retinitis pigmentosa. Doc Ophthalmol. 2006;113(1):5–10. doi: 10.1007/s10633-006-9007-z

[64] Vingolo E.M., Livani M.L., Domanico D., et al. Optical coherence tomography and electro-oculogram abnormalities in X-linked retinitis pigmentosa // Doc Ophthalmol. 2006. Vol. 113, N 1. P. 5–10. doi: 10.1007/s10633-006-9007-z

[65] Grover S, Fishman GA, Anderson RJ, Lindeman M. A longitudinal study of visual function in carriers of X-linked recessive retinitis pigmentosa. Ophthalmology. 2000;107(2):386–396. doi: 10.1016/s0161-6420(99)00045-7

[66] Grover S., Fishman G.A., Anderson R.J., Lindeman M. A longitudinal study of visual function in carriers of X-linked recessive retinitis pigmentosa // Ophthalmology. 2000. Vol. 107, N 2. P. 386–396. doi: 10.1016/s0161-6420(99)00045-7

[67] Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data. Graefes Arch Clin Exp Ophthalmol. 2004;242(6):501–511. doi: 10.1007/s00417-004-0891-1

[68] Wegscheider E., Preising M.N., Lorenz B. Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data // Graefes Arch Clin Exp Ophthalmol. 2004. Vol. 242, N 6. P. 501–511. doi: 10.1007/s00417-004-0891-1

[69] Ogino K, Oishi M, Oishi A, et al. Radial fundus autofluorescence in the periphery in patients with X-linked retinitis pigmentosa. Clin Ophthalmol. 2015;9:1467–1474. doi: 10.2147/OPTH.S89371

[70] Ogino K., Oishi M., Oishi A., et al. Radial fundus autofluorescence in the periphery in patients with X-linked retinitis pigmentosa // Clin Ophthalmol. 2015. Vol. 9. P. 1467–1474. doi: 10.2147/OPTH.S89371

RIGHTS & PERMISSIONS

Eco-Vector